|
|
37781
|
Y54.2
|
ADVERSE EFFECTS IN THERAPEUTIC USE, CARBONIC-ANHYDRASE INHIBITORS
|
|
|
37782
|
Y54.3
|
ADVERSE EFFECTS IN THERAPEUTIC USE, BENZOTHIADIAZINE DERIVATIVES
|
|
|
37783
|
Y54.4
|
ADVERSE EFFECTS IN THERAPEUTIC USE, LOOP [HIGH-CEILING] DIURETICS
|
|
|
37784
|
Y54.5
|
ADVERSE EFFECTS IN THERAPEUTIC USE, OTHER DIURETICS
|
|
|
37785
|
Y54.6
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ELECTROLYTIC, CALORIC AND WATER-BALANCE AGEN More ...
|
|
|
37786
|
Y54.7
|
ADVERSE EFFECTS IN THERAPEUTIC USE, AGENTS AFFECTING CALCIFICATION
|
|
|
37787
|
Y54.8
|
ADVERSE EFFECTS IN THERAPEUTIC USE, AGENTS AFFECTING URIC ACID METABOLISM
|
|
|
37788
|
Y54.9
|
ADVERSE EFFECTS IN THERAPEUTIC USE, MINERAL SALTS, NOT ELSEWHERE CLASSIFIED
|
|
|
37789
|
Y55
|
ADVERSE EFFECTS IN THERAPEUTIC USE, AGENTS PRIMARILY ACTING ON SMOOTH AND SKELET More ...
|
|
|
37790
|
Y55.0
|
ADVERSE EFFECTS IN THERAPEUTIC USE, OXYTOCIC DRUGS
|
|
|
37791
|
Y55.1
|
ADVERSE EFFECTS IN THERAPEUTIC USE, SKELETAL MUSCLE RELAXANTS [NEUROMUSCULAR BLO More ...
|
|
|
37792
|
Y55.2
|
ADVERSE EFFECTS IN THERAPEUTIC USE, OTHER AND UNSPECIFIED AGENTS PRIMARILY ACTIN More ...
|
|
|
37793
|
Y55.3
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ANTITUSSIVES
|
|
|
37794
|
Y55.4
|
ADVERSE EFFECTS IN THERAPEUTIC USE, EXPECTORANTS
|
|
|
37795
|
Y55.5
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ANTI-COMMON-COLD DRUGS
|
|
|
37796
|
Y55.6
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ANTIASTHMATICS, NOT ELSEWHERE CLASSIFIED
|
|
|
37797
|
Y55.7
|
ADVERSE EFFECTS IN THERAPEUTIC USE, OTHER AND UNSPECIFIED AGENTS PRIMARILY ACTIN More ...
|
|
|
37798
|
Y56
|
ADVERSE EFFECTS IN THERAPEUTIC USE, TOPICAL AGENTS PRIMARILY AFFECTING SKIN AND More ...
|
|
|
37799
|
Y56.0
|
ADVERSE EFFECTS IN THERAPEUTIC USE, LOCAL ANTIFUNGAL, ANTI-INFECTIVE AND ANTI-IN More ...
|
|
|
37800
|
Y56.1
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ANTIPRURITICS
|